Modulation of Second Messenger Signaling in the Brain Through PDE4 and PDE5 Inhibition: Therapeutic Implications for Neurological Disorders
Phosphodiesterase (PDE) enzymes regulate intracellular signaling pathways crucial for brain development and the pathophysiology of neurological disorders. Among the 11 PDE subtypes, PDE4 and PDE5 are particularly significant due to their regulation of cyclic adenosine monophosphate (cAMP) and cyclic...
Saved in:
| Main Authors: | Min Kyu Park, Hyun Wook Yang, Seo Young Woo, Dong Yeon Kim, Dae-Soon Son, Bo Young Choi, Sang Won Suh |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-01-01
|
| Series: | Cells |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2073-4409/14/2/86 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PDE Inhibitors and Autophagy Regulators Modulate CRE-Dependent Luciferase Activity in Neuronal Cells from the Mouse Suprachiasmatic Nucleus
by: Erik Maronde, et al.
Published: (2025-08-01) -
Haploinsufficiency of PDE2A causes in mice increased exploratory behavior associated with upregulation of neural nitric oxide synthase in the striatum
by: Ana Gabriela de Oliveira do Rêgo, et al.
Published: (2025-02-01) -
Efficacy and safety of PDE5 inhibitors in middle-aged and old patients with and without hypogonadism
by: Chunlin Wang, et al.
Published: (2024-12-01) -
Age-Related Increases in PDE11A4 Protein Expression Trigger Liquid–Liquid Phase Separation (LLPS) of the Enzyme That Can Be Reversed by PDE11A4 Small Molecule Inhibitors
by: Elvis Amurrio, et al.
Published: (2025-06-01) -
The multifaceted role of phosphodiesterase 4 in tumor: from tumorigenesis to immunotherapy
by: Huili-li Ren, et al.
Published: (2025-03-01)